EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
64.00
0.00 (0.00%)
At close: Jun 4, 2026
6.67% (1Y)
| Market Cap | 114.20M +21.5% |
| Revenue (ttm) | 9.43M +1.5% |
| Net Income | 2.46M +71.3% |
| EPS | 1.38 |
| Shares Out | 1.78M |
| PE Ratio | 46.44 |
| Forward PE | n/a |
| Dividend | 1.83 (2.86%) |
| Ex-Dividend Date | Jun 18, 2026 |
| Volume | 75 |
| Open | 64.00 |
| Previous Close | n/a |
| Day's Range | 64.00 - 64.00 |
| 52-Week Range | 59.00 - 65.50 |
| Beta | 0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 24, 2026 |